EMERYVILLE, Calif., May 2 /PRNewswire-FirstCall/ -- Onyx
Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will webcast a
teleconference with management to discuss first quarter 2007 financial
results and provide a general business overview on Wednesday, May 9, 2007,
at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Financial results for
the first quarter ended March 31, 2007 will be released earlier that day.
Interested parties may access a live webcast of the presentation at:
http://events.streamlogics.net/conferenceplus/onyx/may09-07/index.asp or by
dialing 847-413-3235 and using the passcode 17605023. A replay of the
presentation will be available on the Onyx website or by dialing
630-652-3044 and using the passcode 17605023 approximately one hour after
the teleconference concludes. The replay will be available through June 9,
2007.
Onyx Pharmaceuticals, Inc. is a biopharmaceutical company developing
innovative therapies that target the molecular mechanisms that cause
cancer. The company is developing Nexavar(R), a small molecule drug, with
Bayer Pharmaceuticals Corporation. Nexavar has been approved for the
treatment of advanced kidney cancer. For more information about Onyx's
pipeline and activities, visit the company's web site at:
http://www.onyx-pharm.com.
Nexavar(R) (sorafenib) tablets is a registered trademark of Bayer
Pharmaceuticals Corporation.
SOURCE Onyx Pharmaceuticals, Inc.
 back to top
Related links:
http://www.onyx-pharm.com
CONTACT:
Alex Santos, +1-510-597-6504
|
